These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 809716)

  • 1. Resistance of Trypanosoma cruzi to killing by macrophages.
    Kress Y; Bloom BR; Wittner M; Rowen A; Tanowitz H
    Nature; 1975 Oct; 257(5525):394-6. PubMed ID: 809716
    [No Abstract]   [Full Text] [Related]  

  • 2. Trypanosoma cruzi: uptake and intracellular fate in normal and activated cells.
    Nogueira N; Cohn Z
    Am J Trop Med Hyg; 1977 Nov; 26(6 Pt 2):194-203. PubMed ID: 413447
    [No Abstract]   [Full Text] [Related]  

  • 3. Trypanosoma cruzi: infection of normal and activated mouse macrophages.
    Kress Y; Tanowitz H; Bloom B; Wittner M
    Exp Parasitol; 1977 Apr; 41(2):385-96. PubMed ID: 403086
    [No Abstract]   [Full Text] [Related]  

  • 4. Killing in vitro of Trypanosoma cruzi by macrophages from mice immunized with T. cruzi or BCG, and absence of cross-immunity on challege in vivo.
    Hoff R
    J Exp Med; 1975 Aug; 142(2):299-311. PubMed ID: 806649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG-induced resistance in Trypanosoma cruzi experimental infections.
    Bertelli MS; Alcantara A; Brener Z
    Tropenmed Parasitol; 1981 Jun; 32(2):93-6. PubMed ID: 6789512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptotic lymphocytes treated with IgG from Trypanosoma cruzi infection increase TNF-alpha secretion and reduce parasite replication in macrophages.
    Montalvão F; Almeida GM; Silva EM; Borges VM; Vasconcellos R; Takiya CM; Lopes MF; Nunes MP; DosReis GA
    Eur J Immunol; 2010 Feb; 40(2):417-25. PubMed ID: 19950177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific cutaneous hypersensitivity responses in mice infected or immunized with Trypanosoma cruzi.
    Abrahamsohn IA; Blotta MH; Curotto MA
    Parasite Immunol; 1983 May; 5(3):237-48. PubMed ID: 6408587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro interaction of Trypanosoma cruzi with mouse macrophages and heart muscle cells--film presentation.
    Ax W; Dyonysius J; Hungerer KD
    Adv Exp Med Biol; 1979; 114():673-6. PubMed ID: 111486
    [No Abstract]   [Full Text] [Related]  

  • 9. Macrophages in experimental Chagas' disease.
    Kuhn RE
    Immunol Ser; 1994; 60():495-502. PubMed ID: 8251589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of BCG on the course of experimental Chagas' disease in mice.
    Kuhn RE; Vaughn RT; Herbst GA
    Int J Parasitol; 1975 Oct; 5(5):557-60. PubMed ID: 808508
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of delayed-type hypersensitivity to Trypanosoma cruzi in mice treated with Mycobacterium bovis BCG and cyclophosphamide.
    Abrahamsohn IA; Blotta MH; Curotto MA
    Infect Immun; 1981 Mar; 31(3):1145-51. PubMed ID: 6785239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental Chagas disease: phagocytosis of apoptotic lymphocytes deactivates macrophages and fuels parasite growth.
    Lopes MF; DosReis GA
    Apoptosis; 2000 Jun; 5(3):221-4. PubMed ID: 11225843
    [No Abstract]   [Full Text] [Related]  

  • 13. Phagocytosis: a defense mechanism against infection with Trypanosoma cruzi.
    Kierszenbaum F; Knecht E; Budzko DB; Pizzimenti MC
    J Immunol; 1974 May; 112(5):1839-44. PubMed ID: 4361979
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of silica on resistance to the "Brazil" strain of Trypanosoma cruzi in C57 BL/10 (B10) mice.
    Tanowitz HB; Rager-Zisman B; Wittner M
    Trans R Soc Trop Med Hyg; 1980; 74(6):820-2. PubMed ID: 6259784
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of activated macrophages in resistance of mice to infection with Trypanosoma cruzi.
    Williams DM; Sawyer S; Remington JS
    J Infect Dis; 1976 Dec; 134(6):610-23. PubMed ID: 826595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).
    Silva JS; Twardzik DR; Reed SG
    J Exp Med; 1991 Sep; 174(3):539-45. PubMed ID: 1908509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi.
    Wirth JJ; Kierszenbaum F
    Mol Biochem Parasitol; 1985 Apr; 15(1):1-10. PubMed ID: 2859521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study.
    De Araujo-Jorge TC; Barbosa HS; Meirelles MN
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():43-56. PubMed ID: 1342716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(A)-containing RNA from the spleens of mice with Chagas' disease triggers in vitro macrophage resistance to Trypanosoma cruzi.
    Bertolini MC; De Lucca FL
    J Protozool; 1986 Feb; 33(1):81-4. PubMed ID: 2420985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC; Kahn SJ; Rudensky AY; Van Voorhis WC
    Eur J Immunol; 1997 Dec; 27(12):3085-94. PubMed ID: 9464791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.